BHVN · Biohaven Ltd. · Investor Relations
$12.39
-1.26 (-9.23%)
At close · Nov 20
Return incl. dividend (before tax)
Q4 2021 earnings call transcript
Market Cap
$1.87B
Shares
151.06M
Volume · Nov 20
2.39M
Avg daily vol (3M)
3.22M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-05-27 | Biohaven R&D Day 2026 at Yale School of Management | Event |
| 2026-01-12 | 44th Annual J.P. Morgan Healthcare Conference | Conference |
| 2025-05-28 | Biohaven R&D Day at Yale School of Management | Event |
| 2024-09-23 | Biohaven Topline Pivotal Trial Results for Troriluzole in Spinocerebellar Ataxia | Earnings call |
| 2024-05-29 | Biohaven R&D Day at Yale School of Management | Event |
| 2023-05-31 | Biohaven R&D Day at Yale School of Management | Event |
| 2023-03-15 | 2023 American Society for Experimental Neurotherapeutics Annual Meeting (ASENT 2023) | Shareholder meeting |
Key facts
CIK
1935979
CUSIP
G1110E107
13F (30d)
298 filings
272 filers
Visit website
Investor relations